Earnings summaries and quarterly performance for IVP.
Executive leadership at IVP.
Board of directors at IVP.
Research analysts covering IVP.
Recent press releases and 8-K filings for IVP.
Inspire Veterinary Partners Stock Moves to OTCQB
IVP
Delisting/Listing Issues
Product Launch
- Inspire Veterinary Partners, Inc. (IVP) Class A common stock began trading on the OTCQB Venture Market under the ticker symbol "IVPR" on January 21, 2026.
- This transfer of listing occurred after the company's delisting from The Nasdaq Capital Market due to non-compliance with Nasdaq's minimum bid price requirement.
- The company intends to continue growing existing locations and launch an online pet pharmacy in the first half of 2026.
Jan 21, 2026, 9:15 PM
Inspire Veterinary Partners Secures Convertible Note Financing and Announces Board Resignation
IVP
Debt Issuance
New Projects/Investments
Board Change
- Inspire Veterinary Partners, Inc. entered into a securities purchase agreement with Manetto Hill Fund Series I LLC, effective December 31, 2025, to potentially issue up to $1,626,000 in convertible promissory notes.
- An initial secured convertible promissory note with a $975,000 principal amount was issued for a purchase price of $750,000, carrying a 10% annual interest rate and maturing on December 31, 2026.
- The notes are convertible into common stock at a variable conversion price, with a floor of $0.01 per share, and the company will issue up to 2,500,000 shares of common stock as commitment shares. The proceeds are designated for general working capital and acquisitions.
- Timothy Watters resigned from the company's board of directors, effective January 6, 2026.
Jan 12, 2026, 11:17 AM
Inspire Veterinary Partners Adjusts Floor Price and Amends Debt Agreements
IVP
Convertible Preferred Issuance
Debt Issuance
- On December 1, 2025, Inspire Veterinary Partners, Inc. (IVP) entered into an agreement with Required Holders to lower the Floor Price for its Series B Convertible Preferred Stock from $0.1879 to $0.05 per share.
- Concurrently, on December 1, 2025, the company also secured a waiver agreement from Required Holders to permit a partial redemption of 2,027 shares of Series B Preferred Stock for approximately $2.7 million.
- On December 4, 2025, the company amended promissory notes with Target Capital 1 LLC, reducing the Floor Price from $0.1879 to $0.05 per share and introducing a beneficial ownership limitation that prohibits Target from converting notes if their ownership would exceed 4.99% of outstanding shares.
Dec 5, 2025, 9:15 PM
Inspire Veterinary Partners Issues Senior Convertible Promissory Notes
IVP
Debt Issuance
- Inspire Veterinary Partners, Inc. (IVP) issued Senior Convertible Promissory Notes totaling an original principal amount of $357,142.86 (two notes of $178,571.43 each) to Keystone Capital Partners, LLC and Seven Knots, LLC on November 5, 2025. Each note was purchased for $125,000, reflecting a 30% original issue discount.
- The notes bear a 10% annual interest rate, payable monthly, and have a maturity date of August 5, 2026.
- Holders have the option to convert the notes into Class A common stock at a conversion price equal to 90% of the lowest sale price of the common stock over the twenty trading days immediately prior to conversion.
- The company intends to use the proceeds from the issuance for general working capital purposes.
Nov 10, 2025, 9:15 PM
Inspire Veterinary Partners Amends Securities Purchase Agreement and Completes Additional Closing
IVP
Convertible Preferred Issuance
Debt Issuance
New Projects/Investments
- Inspire Veterinary Partners, Inc. (IVP) entered into an amendment to its Securities Purchase Agreement on September 9, 2025, to add new institutional investors.
- This amendment facilitates the issuance and sale of Series B convertible preferred stock and related Warrants to these new investors.
- An Additional Closing on September 9, 2025, involved the sale of 1,253 shares of Series B Preferred Stock and related Warrants.
- This closing generated approximately $1.0 million in gross proceeds for the company.
- The offering was conducted as a private placement to accredited investors.
Sep 15, 2025, 8:15 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more